Sequential Treatment of Psoriasis With Integrated Traditional Chinese and Western Medicine

NCT03941431 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 378

Last updated 2019-05-08

No results posted yet for this study

Summary

The purpose of this study was to explore intervention time of Chinese medicine and specification of a sequential treatment plan for severe psoriasis with Chinese and Western medicine.

Conditions

Interventions

DRUG

Jueyin granules

Jueyin granules p.o. once a day for 8 weeks.

DEVICE

moving cupping therapy

Moving cupping therapy three times per week for 8 weeks.

DEVICE

NB-UVB therapy

NB-UVB phototherapy three times per week for 8 weeks.

DRUG

Jueyin placebo granules

Jueyin placebo granules p.o. once a day for 8 weeks.

DEVICE

moving cupping placebo therapy

Moving cupping placebo therapy three times per week for 8 weeks.

DEVICE

NB-UVB placebo phototherapy

NB-UVB placebo phototherapy three times per week for 8 weeks.

Sponsors & Collaborators

  • Shanghai Dermatology Hospital

    collaborator OTHER
  • Chinese Medicine Hospital Affiliated to Southwest Medical University

    collaborator UNKNOWN
  • Wuhan No.1 Hospital

    collaborator OTHER
  • The Second People's Hospital Affiliated to Fujian University of TCM

    collaborator UNKNOWN
  • Jiangsu Province Hospital of Traditional Chinese Medicine

    collaborator OTHER
  • Shanghai Yueyang Integrated Medicine Hospital

    lead OTHER

Principal Investigators

  • Jia Zhou · Department of dermatology, Shanghai Yueyang Integrated Medicine Hospital, Shanghai

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-01
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03941431 on ClinicalTrials.gov